Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm

Peer review reports

Original Submission
28 Sep 2021	Submitted	Original manuscript
3 Nov 2021	Reviewed	Reviewer Report - Kirsty Loudon
10 Nov 2021	Author responded	Author comments - Jonathan Golledge
Resubmission - Version 2
10 Nov 2021	Submitted	Manuscript version 2
25 Nov 2021	Author responded	Author comments - Jonathan Golledge
Resubmission - Version 3
25 Nov 2021	Submitted	Manuscript version 3
Publishing
3 Dec 2021	Editorially accepted
27 Dec 2021	Article published	10.1186/s13063-021-05915-0

Back to article page